MG
LLY icon

Marex Group’s Eli Lilly LLY Stock Holding History

Marex Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$184M Buy
200,000
+180,000
+900% +$182M 1.16% 22
2025
Q4 		$21.5M Sell
20,000
-325,000
-94% -$311M 0.14% 120
2025
Q3 		$263M Buy
345,000
+62,500
+22% +$46.5M 1.86% 15
2025
Q2 		$220M Buy
+282,500
New +$220M 1.91% 10

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Marex Group's LLY Position: Q1 2026 in Review

Marex Group increased its Eli Lilly (LLY) stake by 320% in Q1 2026, buying an estimated $113M and bringing the position to 145,674 shares worth $134M. The position accounts for 0.85% of the portfolio, ranked #31.

Marex Group first reported a position in LLY in Q4 2022 and has held it in 13 quarters since. The position peaked at $285M in Q3 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Marex Group held 145,674 shares of Eli Lilly worth $134M as of Q1 2026.
  • Marex Group bought 111,003 Eli Lilly shares in Q1 2026, an estimated $113M.
  • Eli Lilly made up 0.85% of Marex Group's portfolio in Q1 2026, its #31 holding.
  • Marex Group first reported a position in Eli Lilly in Q4 2022 and has held it in 13 quarters since.
  • Marex Group's Eli Lilly position peaked at $285M in Q3 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.